Long Non-coding RNA PVT1 as a Prognostic and Therapeutic Target in Pediatric Cancer.
8q32
PVT1
epigenetic
lncRNA
pediatric cancer
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2019
2019
Historique:
received:
25
03
2019
accepted:
18
10
2019
entrez:
30
11
2019
pubmed:
30
11
2019
medline:
30
11
2019
Statut:
epublish
Résumé
In recent decades, biomedical research has focused on understanding the functionality of the human translated genome, which represents a minor part of all genetic information transcribed from the human genome. However, researchers have become aware of the importance of non-coding RNA species that constitute the vast majority of the transcriptome. In addition to their crucial role in tissue development and homeostasis, mounting evidence shows non-coding RNA to be deregulated and functionally contributing to the development and progression of different types of human disease including cancer both in adults and children. Small non-coding RNAs (i.e., microRNA) are in the vanguard of clinical research which revealed that RNA could be used as disease biomarkers or new therapeutic targets. Furthermore, many more expectations have been raised for long non-coding RNAs, by far the largest fraction of non-coding transcripts, and still fewer findings have been translated into clinical applications. In this review, we center on PVT1, a large and complex long non-coding RNA that usually confers oncogenic properties on different tumor types. We focus on the compilation of early advances in the field of pediatric tumors which often lags behind clinical improvements in adult tumors, and provide a rationale to continue studying PVT1 as a possible functional contributor to pediatric malignancies and as a potential prognostic marker or therapeutic target.
Identifiants
pubmed: 31781490
doi: 10.3389/fonc.2019.01173
pmc: PMC6853055
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1173Informations de copyright
Copyright © 2019 Boloix, Masanas, Jiménez, Antonelli, Soriano, Roma, Sánchez de Toledo, Gallego and Segura.
Références
Cancer Discov. 2011 Oct;1(5):391-407
pubmed: 22096659
DNA Cell Biol. 2017 Sep;36(9):787-793
pubmed: 28731781
Cell Physiol Biochem. 2018;51(5):2324-2340
pubmed: 30537738
Neurotherapeutics. 2018 Oct;15(4):1139-1157
pubmed: 30120709
Biochem Biophys Res Commun. 2016 Feb 26;471(1):10-4
pubmed: 26850852
RNA Biol. 2015;12(4):381-8
pubmed: 25746834
Oncotarget. 2017 May 23;8(21):34164-34176
pubmed: 28404954
Int J Biol Sci. 2019 Jun 2;15(7):1514-1522
pubmed: 31337980
Gene. 2018 May 15;654:36-42
pubmed: 29452232
J Clin Oncol. 2015 Sep 20;33(27):3065-73
pubmed: 26304881
J Cell Physiol. 2019 Apr;234(4):4799-4811
pubmed: 30317572
Oncotarget. 2017 Sep 4;8(43):75455-75466
pubmed: 29088881
Cancer Res. 2011 Aug 15;71(16):5365-9
pubmed: 21828241
Oncogene. 2019 Jun;38(24):4820-4834
pubmed: 30808975
J Cell Physiol. 2007 Nov;213(2):511-8
pubmed: 17503467
Cell Physiol Biochem. 2018;49(4):1403-1419
pubmed: 30205391
Mamm Genome. 2019 Aug;30(7-8):217-225
pubmed: 31222482
J Cell Physiol. 2019 Feb;234(2):1346-1353
pubmed: 30076714
Cancer Sci. 2017 May;108(5):868-876
pubmed: 28235236
Cell. 2010 Aug 6;142(3):409-19
pubmed: 20673990
Oncogene. 2018 Jun;37(25):3426-3439
pubmed: 29555976
Biomed Res Int. 2015;2015:304208
pubmed: 25883951
Science. 2007 Jun 8;316(5830):1484-8
pubmed: 17510325
Annu Rev Biochem. 1992;61:809-60
pubmed: 1497324
J Drug Target. 2017 Aug;25(7):637-644
pubmed: 28296507
EMBO J. 1986 Nov;5(11):2845-51
pubmed: 3024964
Nat Rev Genet. 2009 Mar;10(3):155-9
pubmed: 19188922
Cancer Manag Res. 2019 Jul 24;11:6981-6993
pubmed: 31440087
Genome Res. 2007 May;17(5):556-65
pubmed: 17387145
Curr Top Dev Biol. 2011;94:1-13
pubmed: 21295682
Cancer Chemother Pharmacol. 2019 May;83(5):921-931
pubmed: 30859368
Lancet Oncol. 2017 Jun;18(6):719-731
pubmed: 28410997
Int J Mol Sci. 2018 Apr 27;19(5):null
pubmed: 29702599
Int J Mol Med. 2018 Jul;42(1):489-496
pubmed: 29620147
Exp Ther Med. 2019 Feb;17(2):1337-1345
pubmed: 30680011
PLoS Genet. 2013;9(9):e1003777
pubmed: 24039610
PLoS One. 2011;6(9):e23356
pubmed: 21915259
Cell Biol Int. 2019 Mar;43(3):253-264
pubmed: 30549141
J Cell Physiol. 2020 Feb;235(2):1321-1329
pubmed: 31270819
J Biol Chem. 2012 Jan 20;287(4):2509-19
pubmed: 22110125
Cancer Sci. 2017 Oct;108(10):1927-1933
pubmed: 28776911
Int J Clin Exp Med. 2015 Oct 15;8(10):17110-6
pubmed: 26770304
Pathol Res Pract. 2019 Mar;215(3):555-563
pubmed: 30661902
Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1783-1794
pubmed: 29501773
Genome Res. 2012 Sep;22(9):1775-89
pubmed: 22955988
J Med Genet. 2015 Oct;52(10):710-8
pubmed: 26358722
Nature. 2012 Feb 15;482(7385):339-46
pubmed: 22337053
J Cell Physiol. 2019 Dec;234(12):22996-23004
pubmed: 31131447
Front Genet. 2012 Apr 30;3:69
pubmed: 22558003
Transl Pediatr. 2014 Apr;3(2):156-82
pubmed: 26835334
J Cell Mol Med. 2018 Feb;22(2):1272-1282
pubmed: 29193797
Am J Cancer Res. 2018 Mar 01;8(3):538-550
pubmed: 29637007
Cell. 2007 Jun 29;129(7):1311-23
pubmed: 17604720
Oncol Res. 2018 Jun 11;26(5):675-681
pubmed: 28409552
Oncotarget. 2016 Dec 13;7(50):82620-82633
pubmed: 27813492
Biochem Biophys Res Commun. 2018 Jan 15;495(3):2350-2355
pubmed: 29277611
Nucleic Acids Res. 2019 Apr 8;47(6):e32
pubmed: 30698727
Biomed Pharmacother. 2018 Oct;106:61-67
pubmed: 29957467
Cell Physiol Biochem. 2017;42(6):2453-2466
pubmed: 28848163
Exp Cell Res. 2018 Jan 1;362(1):172-179
pubmed: 29133127
Cell Physiol Biochem. 2018;47(3):893-913
pubmed: 29843138
Nature. 2018 Mar 15;555(7696):371-376
pubmed: 29489755
J Cell Biochem. 2019 Oct;120(10):16567-16574
pubmed: 31081163
Nucleic Acids Res. 2013 Jan;41(Database issue):D239-45
pubmed: 23193281
Biomed Pharmacother. 2017 Apr;88:302-308
pubmed: 28122299
Tumour Biol. 2017 Jun;39(6):1010428317705338
pubmed: 28656879
J Cell Physiol. 2018 May;233(5):4044-4055
pubmed: 28657147
Nat Genet. 2012 May 29;44(6):619-22
pubmed: 22641210
Noncoding RNA Res. 2018 Mar 31;3(3):108-117
pubmed: 30175284
Mol Cancer. 2018 Jul 12;17(1):98
pubmed: 30001707
Int J Biol Sci. 2018 Feb 12;14(3):321-330
pubmed: 29559849
Biomed Pharmacother. 2019 Mar;111:244-250
pubmed: 30590312
Dig Dis Sci. 2017 Nov;62(11):3021-3028
pubmed: 28258379
Genome Biol. 2017 Dec 20;18(1):237
pubmed: 29262850
J Cell Biochem. 2019 Mar;120(3):3911-3921
pubmed: 30304557
Mol Cell Oncol. 2015 Feb 11;2(2):e974467
pubmed: 27308428
Nature. 2014 Aug 7;512(7512):82-6
pubmed: 25043044
Cell. 2011 Aug 5;146(3):353-8
pubmed: 21802130
Oncotarget. 2015 Oct 6;6(30):28882-94
pubmed: 26337084
Clin Cancer Res. 2007 Oct 1;13(19):5745-55
pubmed: 17908964
Oncotarget. 2016 May 31;7(22):32421-32
pubmed: 27107415
Trends Mol Med. 2018 Mar;24(3):257-277
pubmed: 29449148
Pathol Oncol Res. 2019 Oct;25(4):1411-1422
pubmed: 30141114
BMC Genomics. 2018 Aug 23;19(1):631
pubmed: 30139326
Nat Med. 2015 Nov;21(11):1253-61
pubmed: 26540387
EMBO J. 1985 Mar;4(3):675-81
pubmed: 3924592
Biochem Biophys Res Commun. 2019 Aug 20;516(2):486-493
pubmed: 31230752
Med Sci Monit. 2018 Dec 01;24:8685-8692
pubmed: 30504754
Nature. 2018 Mar 15;555(7696):321-327
pubmed: 29489754
Biochem Biophys Res Commun. 2017 Aug 19;490(2):217-224
pubmed: 28602700
Biosci Biotechnol Biochem. 2018 Oct 10;:1-6
pubmed: 30304996
Tumour Biol. 2017 Mar;39(3):1010428317694326
pubmed: 28351322
Sci Rep. 2015 Aug 26;5:13445
pubmed: 26306906
Acta Neuropathol. 2012 Sep;124(3):439-47
pubmed: 22661320
Biochem Biophys Res Commun. 2018 Aug 25;502(4):465-471
pubmed: 29852168
Biochem Biophys Res Commun. 2019 Jan 15;508(3):980-985
pubmed: 30551880
Mol Cancer Res. 2008 Feb;6(2):212-21
pubmed: 18314482
Cancer Cell. 2014 Nov 10;26(5):722-37
pubmed: 25517750
Epigenomics. 2018 Jun;10(6):723-732
pubmed: 29693417
Science. 2005 May 20;308(5725):1149-54
pubmed: 15790807
Onco Targets Ther. 2019 Apr 05;12:2563-2575
pubmed: 31040699
Nucleic Acids Res. 2016 Jan 29;44(2):863-77
pubmed: 26578588
Philos Trans R Soc Lond B Biol Sci. 2018 Jun 5;373(1748):
pubmed: 29685978
Biomed Pharmacother. 2018 Aug;104:686-698
pubmed: 29803929
Gene. 2019 May 20;697:94-102
pubmed: 30794914
Mol Cancer. 2019 Mar 2;18(1):33
pubmed: 30825877
Cancer Lett. 2017 Mar 1;388:208-219
pubmed: 27986464
Nat Rev Mol Cell Biol. 2018 Mar;19(3):143-157
pubmed: 29138516
Pharmacol Res. 2013 Sep;75:3-14
pubmed: 23537752
Oncotarget. 2016 Mar 22;7(12):13810-26
pubmed: 26885613
Curr Opin Genet Dev. 2015 Aug;33:41-8
pubmed: 26254776
Cancer Sci. 2015 Oct;106(10):1323-32
pubmed: 26224446
Cell. 2018 May 31;173(6):1398-1412.e22
pubmed: 29731168
Cancer Cell. 2016 Apr 11;29(4):452-463
pubmed: 27070700
Nature. 2012 Aug 2;488(7409):49-56
pubmed: 22832581
Biomed Pharmacother. 2019 Apr;112:108627
pubmed: 30797143